NanoViricides is trading 5% down today at $1.66 as the stock faces profit-taking following a recent rally and broader pressure on the biotechnology sector.
- The decline follows a strong upward move from approximately $1.51 on July 10 to a peak of $1.75 on July 20.
- There are no fresh company-specific news or filings today; the move appears driven by sector-wide softness, with the XBI biotech ETF down over 2%.
- The price action reflects typical volatility often seen in small clinical-stage biotech companies during periods of market pressure.